Gini F Fleming

An Accessible Communication System for Population-Based Genetic Testing: Development and Usability Study

M. Munsell, B. Norquist, Tara Coffin, 2022, JMIR formative research.

Development and assessment of an accessible communication system for population based genetic testing (Preprint)

B. Norquist, Tara Coffin, Olofunmilayo I. Olopade, 2021, JMIR Formative Research.

Remotely Delivered Cancer Genetic Testing in the Making Genetic Testing Accessible (MAGENTA) Trial: A Randomized Clinical Trial.

O. Olopade, M. Munsell, B. Norquist, 2023, JAMA Oncology.

Using Social Media to Facilitate Communication About Women’s Testing: Tool Validation Study

E. Swisher, M. Munsell, B. Norquist, 2021, JMIR formative research.

A phase II study single agent of aflibercept (VEGF Trap) in patients with recurrent or metastatic gynecologic carcinosarcomas and uterine leiomyosarcoma. A trial of the Princess Margaret Hospital, Chicago and California Cancer Phase II Consortia.

H. Mackay, A. Oza, H. Hirte, 2012, Gynecologic oncology.